Aprea Therapeutics (APRE) Institutional Ownership $3.08 -0.26 (-7.78%) (As of 12/18/2024 05:44 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Aprea Therapeutics (NASDAQ:APRE)CurrentInstitutional OwnershipPercentage34.19%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$603.36KNumber ofInstitutional Sellers(last 12 months)0 Get APRE Insider Trade Alerts Want to know when executives and insiders are buying or selling Aprea Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data APRE Institutional Buying and Selling by Quarter Ad Wealthpin ProI want to send you my Cash CalendarThis Calendar reveals the EXACT dates that — if everything goes right — anyone can target cash payouts of $125, $415, and even $1,665. (With just a $1,000 starting stake!) Granted, there were smaller wins and those that did not work out and we cannot promise future returns or against losses, but these payouts don’t require any special knowledge or skills. Anyone can set them up with just three clicks in their brokerage account. And the money can be deposited in their account the very next morning after opening the trade. Again, I want to send this Cash Calendar to you completely FREE. All you have to do is join me for my free Cash Calendar training right here. You don’t want to miss this. There is a very special bonus surprise for everyone who attends. Reserve your seat. Aprea Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/21/2024 Stonepine Capital Management LLC137,174$558K0.5%N/A2.526% 8/9/2024 Dimensional Fund Advisors LP11,071$45K0.0%N/A0.204% 5/15/2023 AIGH Capital Management LLC345,000$1.53M0.6%N/A9.244% 5/15/2023 Sio Capital Management LLC280,000$1.24M0.6%N/A7.503% 5/12/2022Gyon Technologies Capital Management LP20,570$38K0.0%N/A0.094% 5/12/2022 Magnus Financial Group LLC14,856$28K0.0%-56.3%0.068% Get the Latest News and Ratings for APRE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aprea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/2022 Kennedy Capital Management Inc.336,730$966K0.0%-1.7%1.569% 2/14/2022 PDT Partners LLC142,600$409K0.0%+62.5%0.664% 2/10/2022 Magnus Financial Group LLC33,981$98K0.0%N/A0.158% 11/16/2021 Verition Fund Management LLC20,101$103K0.0%N/A0.094% 11/12/2021 Geode Capital Management LLC198,339$1.01M0.0%+89.9%0.936% 11/10/2021 Goldman Sachs Group Inc.144,758$740K0.0%+131.4%0.683% 11/9/2021BlackRock Inc.354,275$1.81M0.0%-0.9%1.672% 9/17/2021 Virtu Financial LLC41,142$201K0.0%+292.9%0.194% 8/17/2021 Walleye Capital LLC98,931$483K0.0%-16.5%0.467% 8/17/2021 Walleye Trading LLC27,455$134K0.0%-33.4%0.130% 8/16/2021 PDT Partners LLC124,234$606K0.0%N/A0.586% 8/16/2021 Morgan Stanley1,019,776$4.98M0.0%+2.2%4.813% 8/16/2021 Kennedy Capital Management Inc.353,926$1.73M0.0%+575.2%1.670% 8/16/2021 Charles Schwab Investment Management Inc.50,366$246K0.0%-26.5%0.238% 8/16/2021 State Street Corp40,832$199K0.0%-67.2%0.193% 8/16/2021 Goldman Sachs Group Inc.62,546$305K0.0%-14.4%0.295% 8/13/2021 Northern Trust Corp32,530$159K0.0%-69.2%0.154% 8/13/2021 Geode Capital Management LLC104,447$509K0.0%-35.2%0.493% 8/13/2021 Vanguard Group Inc.707,422$3.45M0.0%-6.0%3.339% 8/12/2021 SG Americas Securities LLC598,395$2.92M0.0%-8.8%2.824% 8/12/2021 JPMorgan Chase & Co.60,315$294K0.0%+264.4%0.285% 8/12/2021Ergoteles LLC18,570$91K0.0%N/A0.088% 8/11/2021 Great Lakes Advisors LLC17,895$87K0.0%N/A0.084% 8/11/2021 Bank of New York Mellon Corp16,843$83K0.0%-64.8%0.079% 5/19/2021 Virtu Financial LLC10,471$53K0.0%-56.4%0.049% 5/18/2021 Voloridge Investment Management LLC304,198$1.55M0.0%N/A1.436% 5/18/2021 Morgan Stanley998,127$5.09M0.0%+111.0%4.711% 5/18/2021 Redmile Group LLC694,918$3.54M0.0%-45.2%3.280% 5/17/2021 Royal Bank of Canada15,173$76K0.0%+76.5%0.072% 5/17/2021 Walleye Trading LLC41,254$210K0.0%+7.4%0.195% 5/17/2021 Walleye Capital LLC118,476$604K0.0%+17.5%0.559% 5/17/2021 HRT Financial LP73,587$375K0.0%N/A0.347% 5/17/2021 Nuveen Asset Management LLC17,565$90K0.0%-48.7%0.083% 5/17/2021 5AM Venture Management LLC619,157$3.16M0.6%-55.1%2.922% Why I'm telling friends to avoid gold stocks (Ad)Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown.5/17/2021 Goldman Sachs Group Inc.73,107$373K0.0%N/A0.345% 5/14/2021 Kennedy Capital Management Inc.52,415$267K0.0%N/A0.247% 5/14/2021 FIL Ltd83,191$424K0.0%+17,267.6%0.393% 5/14/2021 UBS Asset Management Americas Inc.22,700$116K0.0%N/A0.107% 5/13/2021 Trexquant Investment LP25,361$129K0.0%N/A0.120% 5/13/2021 SG Americas Securities LLC655,888$3.35M0.0%+2,725.9%3.096% 5/13/2021 Bank of New York Mellon Corp47,783$244K0.0%+57.5%0.226% 5/12/2021 Northern Trust Corp105,719$539K0.0%-6.8%0.499% 5/12/2021 Geode Capital Management LLC161,147$821K0.0%+9.1%0.761% 5/12/2021 JPMorgan Chase & Co.16,550$85K0.0%+380.3%0.078% 5/7/2021BlackRock Inc.810,852$4.14M0.0%-2.1%3.827% 5/7/2021 Versant Venture Management LLC1,259,662$6.42M1.3%-11.7%5.945% 5/3/2021 Zurcher Kantonalbank Zurich Cantonalbank8,254$42K0.0%N/A0.039% 4/16/2021NEXT Financial Group Inc11,765$60K0.0%N/A0.056% 3/12/2021 DekaBank Deutsche Girozentrale7,000$35K0.0%N/A0.033% 2/24/2021 Virtu Financial LLC24,029$118K0.0%N/A0.113% 2/17/2021 Jane Street Group LLC11,856$58K0.0%N/A0.056% 2/16/2021 Walleye Trading LLC38,400$189K0.0%N/A0.181% 2/16/2021 Walleye Capital LLC100,800$496K0.0%N/A0.476% 2/16/2021 Squarepoint Ops LLC26,182$129K0.0%+179.4%0.124% 2/16/2021 Nuveen Asset Management LLC34,257$169K0.0%+20.5%0.162% 2/16/2021 Price T Rowe Associates Inc. MD29,874$147K0.0%-90.2%0.141% 2/16/2021Gyon Technologies Capital Management LP41,801$206K0.1%N/A0.197% 2/12/2021 Caas Capital Management LP184,073$906K0.0%N/A0.869% 2/12/2021Credit Suisse AG33,976$167K0.0%+201.3%0.160% 2/11/2021 Northern Trust Corp113,424$559K0.0%-3.9%0.535% 2/10/2021 Artisan Partners Limited Partnership517,771$2.55M0.0%+77.9%2.444% 2/9/2021 Wells Fargo & Company MN5,523$27K0.0%-55.4%0.026% 2/9/2021 Bank of New York Mellon Corp30,336$149K0.0%+6.4%0.143% 2/5/2021BlackRock Inc.828,568$4.08M0.0%+69.6%3.911% 2/5/2021 SG Americas Securities LLC23,210$114K0.0%-24.3%0.110% 1/22/2021 Candriam Luxembourg S.C.A.362,346$1.78M0.0%+54.9%1.710% 1/21/2021 Hershey Trust Co.9,822$48K0.0%N/A0.046% 11/16/2020 Cubist Systematic Strategies LLC1,919$46K0.0%N/A0.009% 11/16/2020 Squarepoint Ops LLC9,371$225K0.0%N/A0.044% 11/13/2020 Morgan Stanley67,774$1.63M0.0%-4.1%0.320% 11/13/2020 Charles Schwab Investment Management Inc.70,748$1.70M0.0%+64.0%0.334% 11/10/2020 State Street Corp128,112$3.08M0.0%+4.2%0.605% 11/5/2020 Wells Fargo & Company MN12,370$298K0.0%+6.5%0.058% (Data available from 1/1/2016 forward) APRE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of APRE shares? During the previous two years, the following institutional investors and hedge funds held shares of Aprea Therapeutics shares: AIGH Capital Management LLC ($1.53M), Sio Capital Management LLC ($1.24M), and Stonepine Capital Management LLC ($558K), Dimensional Fund Advisors LP ($45K).Learn more on APRE's institutional investors. What percentage of Aprea Therapeutics stock is owned by institutional investors? 34.19% of Aprea Therapeutics stock is owned by institutional investors. Learn more on APRE's institutional investor holdings. Which institutional investors have been buying Aprea Therapeutics stock? The following institutional investors have purchased Aprea Therapeutics stock in the last 24 months: AIGH Capital Management LLC ($345K), Sio Capital Management LLC ($280K), Stonepine Capital Management LLC ($137.17K), and Dimensional Fund Advisors LP ($11.07K). How much institutional buying is happening at Aprea Therapeutics? Institutional investors have bought a total of 773,245 shares in the last 24 months. This purchase volume represents approximately $3.38M in transactions. Related Companies RPTX Institutional Ownership VOR Institutional Ownership VHAQ Institutional Ownership BCAB Institutional Ownership CUE Institutional Ownership SLS Institutional Ownership OSTX Institutional Ownership INCR Institutional Ownership DBVT Institutional Ownership ONCY Institutional Ownership This page (NASDAQ:APRE) was last updated on 12/19/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aprea Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aprea Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APRE Stock Alerts